Tango Therapeutics (TNGX)
Develops MTAP-selective PRMT5 inhibitors for genetically defined cancers.
$24.19
vs last close+1.86 (+8.33%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
estimated · in 42 days
EPS estimate
−$0.34
Revenue estimate
$3.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.35−$0.36−$0.35$0.13−$0.29−$0.32−$0.37Pending
Estimate−$0.32−$0.34−$0.35$0.01−$0.31−$0.31−$0.32−$0.34
Surprise−9.4%−5.9%0.0%+1,200.0%+6.5%−2.0%−16.6%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$4.1M$5.4M$3.2M$53.8M———Pending
Estimate$8.0M$6.4M$6.4M$556.0K$500.4K$578.1K$1.6M$3.3M
Surprise−48.6%−15.2%−50.3%+9,578.2%————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.44 | — | — |
| Sep 2027 | −$0.43 | — | — |
| Jun 2027 | −$0.40 | — | — |
| Mar 2027 | −$0.38 | — | — |
| Dec 2026 | −$0.38 | — | — |
| Nov 2026 | −$0.34 | — | — |
| Aug 2026 | −$0.32 | −$0.37 | −16.6% |
| May 2026 | −$0.31 | −$0.32 | −2.0% |
| Mar 2026 | −$0.31 | −$0.29 | +6.5% |
| Nov 2025 | $0.01 | $0.13 | +1,200.0% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jul 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.44 | — | — | $1.3M | — | — | — |
| Sep 2027 | −$0.43 | — | — | $1.3M | — | — | — |
| Jun 2027 | −$0.40 | — | — | $1.3M | — | — | — |
| Mar 2027 | −$0.38 | — | — | $1.3M | — | — | — |
| Dec 2026 | −$0.38 | — | — | $636.7K | — | — | — |
| Nov 3, 2026 | −$0.34 | — | — | $3.3M | — | — | — |
| Aug 10, 2026 | −$0.32 | −$0.37 | −16.6% | $1.6M | — | — | +2.2% |
| May 13, 2026 | −$0.31 | −$0.32 | −2.0% | $578.1K | — | — | −2.5% |
| Mar 5, 2026 | −$0.31 | −$0.29 | +6.5% | $500.4K | — | — | +36.3% |
| Nov 4, 2025 | $0.01 | $0.13 | +1,200.0% | $556.0K | $53.8M | +9,578.2% | 0.0% |
| Aug 5, 2025 | |||||||
| May 12, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 18, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 27, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 28, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 6, 2021 | |||||||
| Jul 17, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Nov 13, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |